Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuplin PRO 22.5 mg safety surveillance in premenopausal breast cancer
jRCT1080223148Completed
- Sponsor
- Takeda
- Start
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of Leuplin PRO in breast cancer, sponsored by Takeda. Started Mar 2016; status: completed.
02
Drugs
Leuplin PRO
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT1080223148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223148.